4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-006170
CHIEF ACCOUNTING OFFICER sold 14,785 shares at an average $21.57 ($318,881)
- CHIEF ACCOUNTING OFFICER acquired 14,785 shares (option exercise)
- CHIEF ACCOUNTING OFFICER acquired 583 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-01-15 | Grant or award 10b5-1 | +583 | $12.35 | $7,200 | 17,588 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-02-28 | Option exercise 10b5-1 | +5,126 | $8.83 | $45,263 | 22,714 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-02-28 | Sale 10b5-1 | −5,126 | $21.79 | $111,696 | 17,588 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-03-01 | Option exercise 10b5-1 | +5,645 | $8.83 | $49,845 | 23,233 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-03-01 | Option exercise 10b5-1 | +4,014 | $13.88 | $55,714 | 27,247 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-03-01 | Sale 10b5-1 | −9,659 | $21.45 | $207,186 | 17,588 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-02-28 | Option exercise · Share Option 10b5-1 | −5,126 | 5,874 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-03-01 | Option exercise · Share Option 10b5-1 | −5,645 | 229 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-03-01 | Option exercise · Share Option 10b5-1 | −4,014 | 0 | D | ||
| Open-market sales · 14,785 sh · avg $21.57 · $318,881 | |||||||
Loading xslF345X05/form4-03012024_110310.xml…